EHP Funds’s Cardio Diagnostics Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-228,952
Closed -$24.4K – 89
2024
Q1
$24.4K Hold
228,952
– – 0.01% 127
2023
Q4
$39.8K Hold
228,952
– – 0.01% 134
2023
Q3
$9.4K Hold
228,952
– – ﹤0.01% 231
2023
Q2
$43.2K Hold
228,952
– – 0.01% 180
2023
Q1
$73.2K Sell
228,952
-135,540
-37% -$31.8K 0.01% 183
2022
Q4
$18K Buy
364,492
+2,100
+0.6% +$250 ﹤0.01% 262
2022
Q3
$60K Buy
362,392
+17,300
+5% +$2.43K 0.01% 270
2022
Q2
$55K Buy
345,092
+54,875
+19% +$10.7K 0.01% 318
2022
Q1
$58K Buy
+290,217
New +$69K 0.01% 294

Other funds holding CDIOW

EHP Funds's CDIOW Position: Q2 2024 in Review

EHP Funds sold out of Cardio Diagnostics Warrant (CDIOW) in Q2 2024, closing a stake of 228,952 shares — an estimated $24.4K sold.

EHP Funds first reported a position in CDIOW in Q1 2022 and held it in 9 quarters. The position peaked at $73.2K in Q1 2023. 9 funds tracked by Wall St. Rank hold CDIOW as of Q2 2024.

  • EHP Funds reported no remaining Cardio Diagnostics Warrant position as of Q2 2024 after selling out during the quarter.
  • EHP Funds sold 228,952 Cardio Diagnostics Warrant shares in Q2 2024, an estimated $24.4K.
  • EHP Funds first reported a position in Cardio Diagnostics Warrant in Q1 2022 and held it in 9 quarters.
  • EHP Funds's Cardio Diagnostics Warrant position peaked at $73.2K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Cardio Diagnostics Warrant as of Q2 2024.

Based on EHP Funds's 13F filing for Q2 2024, filed 14 Aug 2024.